TENNOR THERAP-B 06872Hong Kong Stock Exchange

106.1001.76%( -1.900 )
Closed: Oct 9 · Delayed · Hong Kong Stock Exchange
TENNOR THERAP-B (06872) Company Profile - Company Info, Industry & Management - cibo

Company Information

Company Name
TenNor Therapeutics (Suzhou) Limited
Market
HKEX Main Board
Listing Date
2026-05-22
Industry
Innovative Drugs & Biologics
Fiscal Year End
Dec 31
ISIN
CNE100007KG6

Industry

Innovative Drugs & Biologics 0.02%
124 stocks in this industry
Down 52 Up 57
Industry RankingsValue (HKD)Rank
Net Profit (Last FY)-179.70M74/125
ROE (Last FY)-99.60%107/117

Change is the 2026-10-09 close against the previous close; the industry change is the equal-weighted average of its stocks. Sub-industry classification is maintained by cibo. Last FY is each company's latest annual report. Net profit is profit attributable to owners of the parent; ROE = net profit / closing equity attributable to owners. Non-HKD statements are converted at ECB reference rates.

Management

NamePosition
Ma Zhenkun Executive Director
Song Gaoguang Non-Executive Director
Lee Wai Kong, Albert Independent Non-Executive Director
Ni Lin Independent Non-Executive Director
Li Leping Independent Non-Executive Director

Board list from the HKEXnews "List of Directors and their Role and Function", as of 2026-06-08.

About this page

This page shows TENNOR THERAP-B (06872) company information, related securities, the price change distribution and in-industry rankings within its sub-industry, and the board of directors. Quotes come from HKEX Daily Quotations, financial metrics from each company's latest annual report, and the director list from HKEXnews.